◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › R › RDY

Dr. Reddy’s Laboratories Ltd ADR (RDY) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · DATA UPDATED 2026-07-29

Dr. Reddy’s Laboratories Ltd ADR (RDY) operates in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry and is headquartered in Hyderabad, India with about 27,527 employees. Its market capitalization is roughly $10 billion. In the fiscal year ended 2026-03-31, RDY reported ₹353.5B in revenue and ₹45.1B in net income.

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment.

Interactive charts & full statements → Open the RDY valuation workbench →

RDY Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
Total Revenue₹332.8B₹353.5B₹325.5B₹279.2B₹245.9B₹214.4B₹2.6B₹174.6B₹153.9B₹142.0B₹140.8B₹154.7B₹148.2B₹132.2B₹116.3B₹96.7B₹74.7B₹70.3B₹69.4B₹50.0B₹65.2B
Gross Profit₹166.9B₹186.5B₹190.4B₹163.6B₹139.3B₹113.8B₹1.3B₹94.0B₹83.4B₹76.3B₹78.4B₹92.3B₹85.4B₹75.8B₹60.6B₹53.3B₹40.3B₹36.3B₹36.5B₹25.4B₹30.9B
Gross Margin %50.1%52.8%58.5%58.6%56.7%53.1%50.8%53.8%54.2%53.7%55.6%59.7%57.6%57.4%52.1%55.1%53.9%51.7%52.6%50.8%47.4%
Operating Income (EBIT)₹35.2B₹48.9B₹71.8B₹67.7B₹57.1B₹29.5B₹431M₹16.0B₹20.9B₹11.9B₹13.5B₹29.6B₹26.3B₹26.0B₹21.1B₹18.3B₹12.6B₹2.0B(₹2.8B)₹3.4B₹11.3B
Operating Margin %10.6%13.8%22.1%24.3%23.2%13.8%16.9%9.2%13.6%8.4%9.6%19.1%17.7%19.7%18.2%18.9%16.9%2.9%-4.1%6.7%17.2%
Net Income₹33.2B₹45.1B₹56.5B₹55.7B₹45.1B₹23.6B₹232M₹19.5B₹18.8B₹9.8B₹12.0B₹20.0B₹22.2B₹21.5B₹16.8B₹14.3B₹11.0B₹1.1B(₹5.2B)₹4.7B₹9.3B
Net Margin %10.0%12.8%17.4%20.0%18.3%11.0%9.1%11.2%12.2%6.9%8.6%12.9%15.0%16.3%14.4%14.7%14.8%1.5%-7.4%9.4%14.3%
EBITDA₹55.6B₹83.3B₹96.7B₹88.4B₹74.4B₹45.1B₹535M₹41.8B₹35.5B₹23.6B₹24.8B₹39.9B₹34.4B₹33.1B₹22.5B₹20.3B₹16.8B₹6.6B₹1.5B₹7.3B₹14.3B
Earnings Per Share (EPS)₹39.81₹54.11₹67.77₹66.80₹54.17₹28.34₹0.28₹23.48₹22.62₹11.80₹14.42₹23.40₹25.95₹25.21₹19.69₹16.76₹12.99₹1.26₹-6.14₹5.55₹11.74
Shares Outstanding (M)833M833M834M834M832M832M832M830M831M831M835M855M855M853M852M851M850M848M842M843M796M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RDY Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue₹81.2B₹76.3B₹87.3B₹88.1B₹85.5B₹85.1B₹83.6B₹80.2B
Gross Profit₹37.8B₹34.2B₹46.8B₹48.1B₹48.6B₹47.3B₹49.1B₹47.8B
Gross Margin %46.5%44.8%53.6%54.7%56.9%55.6%58.7%59.6%
Operating Income (EBIT)₹3.0B₹473M₹14.2B₹17.5B₹17.5B₹17.6B₹18.7B₹17.6B
Operating Margin %3.7%0.6%16.3%19.9%20.4%20.8%22.4%21.9%
Net Income₹4.5B₹2.2B₹12.1B₹14.4B₹14.2B₹15.9B₹14.1B₹12.6B
Net Margin %5.5%2.9%13.9%16.3%16.6%18.7%16.9%15.7%
EBITDA₹3.0B₹8.8B₹19.6B₹24.3B₹24.6B₹25.3B₹24.3B₹23.9B
Earnings Per Share (EPS)₹5.36₹2.68₹14.52₹17.25₹17.02₹19.10₹16.94₹15.05
Shares Outstanding (M)833M835M833M833M833M834M834M834M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RDY Free Cash Flow History

Cash flowTTM → 2026-06-302026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
Cash from Operations (CFO)₹41.0B₹56.6B₹46.4B₹45.4B₹58.9B₹28.1B₹35.7B₹29.8B₹28.7B₹18.0B₹21.5B₹41.2B₹25.0B₹19.5B₹13.3B₹16.1B₹8.0B₹13.2B₹4.5B₹6.1B₹11.8B
Capital Expenditures (CapEx)₹25.8B₹24.5B₹34.4B₹27.4B₹18.9B₹19.0B₹12.6B₹6.1B₹7.5B₹11.0B₹41.0B₹14.9B₹15.3B₹10.6B₹7.3B₹8.6B₹11.6B₹4.3B₹4.8B₹6.8B₹4.7B
Free Cash Flow (FCF)₹15.1B₹32.1B₹12.0B₹18.0B₹40.0B₹9.1B₹23.1B₹23.7B₹21.2B₹7.0B(₹19.5B)₹26.4B₹9.7B₹8.8B₹6.0B₹7.6B(₹3.6B)₹8.9B(₹256M)(₹647M)₹7.1B
FCF Margin %4.5%9.1%3.7%6.5%16.3%4.2%905.5%13.6%13.8%4.9%-13.8%17.1%6.6%6.7%5.1%7.8%-4.8%12.7%-0.4%-1.3%10.9%
Dividends Paid₹6.8B₹7.0B₹6.7B₹6.6B₹5.0B₹4.1B₹4.1B₹3.9B₹4.0B₹4.0B₹3.4B₹4.1B₹3.1B₹3.0B₹2.7B₹2.2B₹3.1B₹1.2B₹738M₹737M₹439M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RDY Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)(₹927M)₹15.4B₹10.9B₹15.6B₹14.6B₹22.0B₹6.6B₹9.3B
Capital Expenditures (CapEx)₹3.7B₹4.7B₹7.3B₹10.1B₹10.1B₹11.2B₹8.8B₹7.9B
Free Cash Flow (FCF)(₹4.6B)₹10.7B₹3.6B₹5.4B₹4.5B₹10.8B(₹2.2B)₹1.4B
FCF Margin %-5.7%14.1%4.1%6.2%5.2%12.6%-2.6%1.8%
Dividends Paid₹0M₹41M₹113M₹6.7B₹0M₹6.7B₹0M₹6.7B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RDY Balance Sheet History

Balance sheet2026-06-302026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
Total Assets₹575.3B₹567.9B₹493.0B₹387.5B₹321.9B₹292.8B₹3.6B₹3.1B₹225.4B₹225.6B₹219.8B₹207.7B₹194.8B₹170.2B₹1.42T₹119.5B₹95.0B₹80.3B₹83.8B₹85.4B₹86.1B
Cash & Cash Equivalents₹11.2B₹15.1B₹14.7B₹7.1B₹5.8B₹14.9B₹203M₹27M₹2.2B₹2.6B₹18.1B₹40.0B₹39.7B₹33.5B₹51.4B₹18.2B₹5.7B₹6.6B₹5.6B₹7.4B₹18.0B
Total Liabilities₹188.6B₹195.0B₹155.8B₹107.0B₹90.9B₹102.3B₹1.3B₹1.0B₹85.2B₹99.1B₹95.8B₹79.3B₹83.5B₹79.4B₹692.6B₹62.0B₹49.0B₹37.4B₹41.7B₹38.4B₹44.4B
Total Debt (Short + Long-Term)₹60.1B₹76.1B₹42.7B₹17.8B₹12.2B₹33.8B₹6.6B₹275M₹37.8B₹50.1B₹48.6B₹32.8B₹28.9B₹24.3B₹24.4B₹16.2B₹18.4B₹9.4B₹9.8B₹7.0B₹4.1B
Total Shareholders' Equity₹383.4B₹369.6B₹333.4B₹280.6B₹231.0B₹190.5B₹2.4B₹2.0B₹140.2B₹126.5B₹124.0B₹128.3B₹111.3B₹90.8B₹730.9B₹57.4B₹46.0B₹42.9B₹42.0B₹47.1B₹41.7B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RDY viewer.

RDY Metric Deep Dives

Other Companies in DRUG MANUFACTURERS - SPECIALTY & GENERIC

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← RDWUAll “R” companiesRDYN →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.